IFP Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-563
Closed -$3.05K – 5291
2026
Q2
$3.05K Buy
+563
New +$2.16K ﹤0.01% 4048
2025
Q2
– Hold
0
– – – 3689
2025
Q1
– Hold
0
– – – 3994
2024
Q4
– Hold
0
– – – 4160
2023
Q2
– Sell
-68
Closed -$1.35K – 3481
2023
Q1
$1.35K Sell
68
-18
-21% -$569 ﹤0.01% 3019
2022
Q4
$3K Sell
86
-476
-85% -$13.6K ﹤0.01% 3999
2022
Q3
$18K Buy
562
+503
+853% +$17.7K ﹤0.01% 3179
2022
Q2
$2K Hold
59
– – ﹤0.01% 4112
2022
Q1
$2K Buy
59
+56
+1,867% +$1.47K ﹤0.01% 4109
2021
Q4
$1K Buy
+3
New +$86 ﹤0.01% 2990
2019
Q1
– Sell
-9
Closed – – 2665
2018
Q4
$0 Sell
9
-200
-96% -$4.63K ﹤0.01% 3626
2018
Q3
$6K Buy
209
+91
+77% +$2.17K ﹤0.01% 3122
2018
Q2
$2K Sell
118
-48
-29% -$909 ﹤0.01% 3575
2018
Q1
$2K Hold
166
– – ﹤0.01% 3492
2017
Q4
$2K Buy
166
+157
+1,744% +$2.21K ﹤0.01% 3543
2017
Q3
$0 Hold
9
– – ﹤0.01% 4103
2017
Q2
$0 Buy
+9
New +$216 ﹤0.01% 4114

Other funds holding EVH

IFP Advisors's EVH Position: Q3 2026 in Review

IFP Advisors sold out of Evolent Health (EVH) in Q3 2026, closing a stake of 563 shares — an estimated $3.05K sold.

IFP Advisors first reported a position in EVH in Q2 2017 and held it in 14 quarters. The position peaked at $18K in Q3 2022. 34 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • IFP Advisors reported no remaining Evolent Health position as of Q3 2026 after selling out during the quarter.
  • IFP Advisors sold 563 Evolent Health shares in Q3 2026, an estimated $3.05K.
  • IFP Advisors first reported a position in Evolent Health in Q2 2017 and held it in 14 quarters.
  • IFP Advisors's Evolent Health position peaked at $18K in Q3 2022.
  • 34 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.